Angela Brienzo Frey

Title: Angela Brienzo Frey: Innovator in Cell Adhesion Modulation

Introduction

Angela Brienzo Frey is a notable inventor based in Waukesha, Wisconsin. She has made significant contributions to the field of biotechnology, particularly in the area of cell adhesion modulation. Her work has implications for various applications in medical and biological research.

Latest Patents

Angela holds a patent for "Peptides with β1 integrin subunit dependent cell adhesion modulating activity." This patent describes peptides capable of modulating β1 integrin subunit dependent cell adhesion. These peptides include a C-terminal aromatic amino acid residue and an amino acid residue with a lipophilic alkyl side chain as the penultimate C-terminal residue. The 'LipAr' C-terminated peptides are designed to modulate the β1 integrin subunit dependent adhesion of cells, such as Ramos cells. She has 1 patent to her name.

Career Highlights

Angela is affiliated with the University of Minnesota, where she continues her research and development in the field of cell biology. Her innovative work has garnered attention and respect within the scientific community.

Collaborations

Angela has collaborated with esteemed colleagues, including James B McCarthy and Leo T Furcht. These collaborations have further enriched her research and contributed to advancements in her field.

Conclusion

Angela Brienzo Frey is a pioneering inventor whose work in cell adhesion modulation is paving the way for future innovations in biotechnology. Her contributions are vital to understanding and manipulating cellular interactions, which can lead to significant advancements in medical research.